Global Breast Cancer Screening Market Growth 2023-2029

Global Breast Cancer Screening Market Growth 2023-2029

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.

A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.

LPI (LP Information)' newest research report, the “Breast Cancer Screening Industry Forecast” looks at past sales and reviews total world Breast Cancer Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Breast Cancer Screening sales for 2023 through 2029. With Breast Cancer Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast Cancer Screening industry.

This Insight Report provides a comprehensive analysis of the global Breast Cancer Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breast Cancer Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Breast Cancer Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast Cancer Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast Cancer Screening.

The global Breast Cancer Screening market size is projected to grow from US$ 47 million in 2022 to US$ 84 million in 2029; it is expected to grow at a CAGR of 84 from 2023 to 2029.

Global Breast Cancer Screening key players include Hologic, GE Healthcare, Siemen Healthineers, etc. Global top three manufacturers hold a share about 65%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, both have a share about 40 percent.

In terms of product, Mammography Screening is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospital, followed by Clinic.

This report presents a comprehensive overview, market shares, and growth opportunities of Breast Cancer Screening market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Mammography Screening

Breast Magnetic Resonance Imaging (MRI) Screening

Breast Ultrasound Screening

Segmentation by application

Hospital

Clinic

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Hologic

GE Healthcare

Siemen Healthineers

Philips Healthcare

Canon Medical

Fujifilm

Metaltronica

Sino Medical-Device

IMS Srl

Key Questions Addressed in this Report

What is the 10-year outlook for the global Breast Cancer Screening market?

What factors are driving Breast Cancer Screening market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Breast Cancer Screening market opportunities vary by end market size?

How does Breast Cancer Screening break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.